Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy – Trending News

Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy

A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights

EU clears Pfizer’s $43 bn takeover of biotech firm Seagen

Seagen ticks higher as EU approves $43B sale to Pfizer

Seagens planned $43 billion sale to Pfizer receives European antitrust regulator approval.

Pfizer (NYSE:PFE) Slides despite EU Nod to Seagen Acquisition – TipRanks.com

Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy

U.S. pharmaceutical company Pfizer gained unconditional EU antitrust approval on Thursday for its proposed $43 billion acquisition of cancer drug maker Seagen. Pfizer announced the deal in March, its largest purchase in a string of recent acquisitions thanks to a once-in-a-lifetime cash windfall from its COVID-19 vaccine and treatment. The European Commission said the deal would not significantly reduce competition in the 27-country European Union nor would it have a negative impact on prices.

Pfizer (NYSE:PFE) Provides FTC with Documents for Seagen Acquisition – …